OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator. This document is also available as Markdown.

2024-07-31-accounts

==> picture [500 x 33] intentionally omitted <==

NATIONAL HEART & LUNG FOUNDATION

==> picture [500 x 138] intentionally omitted <==

TRUSTEES’ REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31st JULY 2024

==> picture [500 x 143] intentionally omitted <==

Registered Charity No. 1048073

NATIONAL HEART & LUNG FOUNDATION

REFERENCE AND ADMINISTRATIVE INFORMATION

The National Heart and Lung Foundation (“the Foundation”) is an independent charitable foundation, registered with the Charity Commission for England and Wales, registration number 1048073. The Foundation is recognised by HMRC as an approved charity for tax purposes reference number XR10956. The Foundation has a corporate trustee namely “The Trustees of the National Heart and Lung Foundation”

Principal Office Guy Scadding Building, Dovehouse Street, London SW3 6LY

Trustees Richard Reid, Chairman Magdalene Brereton Professor Kim Fox Professor Sir Malcolm Green Dr Michael Harding Professor Charles Knight Ludovic Lindsay Baroness (Sally) Morgan of Huyton

Secretary to the Trustees

Mrs Caroline M Wicks

Bankers The Royal Bank of Scotland plc 36 St Andrew Square, Edinburgh EH2 2YB Auditors Knox Cropper LLP, Chartered Accountants, 65 Leadenhall Street, London EC3A 2AD

Investment Manager Sarasin & Partners LLP Juxon House, 100 St. Paul’s Churchyard, London EC4M 8BU Website www.nhlf.info

Annual Report and Accounts for year ended 31 July 2024 Page 1

NATIONAL HEART & LUNG FOUNDATION

STRUCTURE, GOVERNANCE AND MANAGEMENT

The Foundation is governed by a Trust Deed dated 3 July 1995 and the Deed of Amendment 2015. The funds of the Foundation are made up of a capital fund (£15,557,167), which is an expendable endowment, an unrestricted General Fund (£5,242,019) and one restricted fund; the Viscount Royston Fellowship Fund (£2,787,625) which is dedicated in perpetuity to research into diseases of the heart muscle and into heart disease generally.

The Board of Trustees meets twice a year and is responsible for the management of the Foundation. Day to day managerial responsibility is delegated to the Secretary to the Trustees. The Foundation seeks to achieve its objects by careful stewardship of its existing assets augmented by income from voluntary donations and legacies. It has no employees and does not actively fundraise. The NHLF website includes a link to the NHLF privacy policy.

The Trustees have identified and considered the strategic, operational and financial risks to which the Foundation is exposed and they are satisfied that there is appropriate protection, systems and checks in place to mitigate exposure to these risks. With regard to risks arising from the Foundation’s financial investments, Trustees are kept fully informed by their independent investment managers, who provide reports and statements quarterly, and more frequently on request. Face to face and telephone meetings occur between Trustees and the investment managers during the year.

GRANT-MAKING AIMS AND OBJECTIVES – PUBLIC BENEFIT

When reviewing the Foundation’s aims and objectives, setting the grant making policy and awarding grants, the Trustees have complied with section 2(1)(b) of the Charities Act 2011 and have had due regard to the Charity Commission’s guidance on public benefit.

GRANT ACTIVITY – CURRENT INITIATIVES

The Foundation assists the National Heart & Lung Institute by providing grants, facilities, equipment and premises and such other assistance as the Trustees shall determine. Current initiatives are:

The charity has made grant commitments totalling £534k as at the end of July 2024.

Annual Report and Accounts for year ended 31 July 2024 Page 2

NATIONAL HEART & LUNG FOUNDATION

FINANCIAL STRATEGY AND RESERVES

The Foundation’s current spending policy is to limit annual net cash outgoings, excluding items of extraordinary expenditure, to an amount that the Trustees believe will not significantly reduce the medium or longer term value of the investments. The Foundation has a reasonable expectation that its resources are adequate to continue in operational existence for the foreseeable future and that there are no material uncertainties that call into doubt its ability to continue. The financial statements have, therefore, been prepared on the basis of a going concern.

Income from all sources totalled £899,496 (2023: £659,762). Total expenditure was £176,555 (2023: £809,077). Net gains on investments for the year were £1,720,187 (2023: losses £256,117) which left a surplus for the year of £2,443,128 (2023 deficit £405,432). During the year, new grant commitments totalling £40,000, were made.

Performance

The total value of the Foundation’s investments at 31 July 2024 was £18,848,737 (£17,278,181 at 31 July 2023). There is no investment in tobacco related companies. Investments are held exclusively in trusts managed by Sarasin investment managers:-

2024
Investment in unit trusts
18,807,430
Cash held for investment purposes
17,307
£18,824,737
s held in unit trusts include the following asset allocations:-
Fixed Income
2,060,000
Equities
14,055,748
Property
658,766
Alternative Assets
1,422,848
Liquid Assets
627,375
£18,824,737
2023
£
17,252,294
25,887
£17,278,181
2,517,726
11,479,720
703,575
1,611,787
965,373
£17,278,181

The units held in unit trusts include the following asset allocations:-

The year-end results and fund balances are set out in the Statement of Financial Activities on page 7 and Balance Sheet on page 8.

Annual Report and Accounts for year ended 31 July 2024 Page 3

NATIONAL HEART & LUNG FOUNDATION

Trustees’ responsibilities for the financial statements

The Trustees are responsible for preparing their annual report and the financial statements for each financial year in accordance with applicable law and UK accounting standards. The law applicable to charities in England and Wales requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of the Foundation’s financial position at the year end and its financial activities for that period. In preparing those financial statements, the Trustees are required to:

The Trustees are responsible for keeping proper records which disclose with reasonable accuracy the financial position of the charity and that enable them to ensure that the financial statements comply with relevant legislation and the provisions of the Trust Deed. They are responsible for safeguarding the charity’s assets and taking reasonable steps for the prevention and detection of fraud and breaches of law and regulations. The Trustees are also responsible for the maintenance and integrity of any financial information included on the charity’s website.

FUTURE PLANS

For the foreseeable future, the Trustees have resolved to continue to preserve as far as possible the capital base of the Foundation’s investments, and to maximise the opportunity to make grants. The Trustees have commenced the process of changing the Charitable Status of the National Heart & Lung Foundation to become a Charitable Company Limited by Guarantee and this is anticipated to have been completed during the next accounting period.

VOLUNTARY INCOME

Whilst maintaining its policy of not actively fundraising, Trustees continue to welcome the support of donors to the Foundation. Donations are often made in memory of loved ones.

In addition, the Foundation receives income from legacies, and its policy is to recognise legacies when the charity is entitled to receipt and the amount can be measured with reasonable certainty. This year the Trustees wish to acknowledge legacies received from the estates of Raymond Henson, Linda May Milton, Roger Philip Selman, and Richard Michael Trezise.

The Foundation knows of some additional legacy payments amounting to approximately £383k which it expects to receive during the forthcoming year. Details of these will be included in future financial statements.

Approved by the Trustees and signed on their behalf

R H Reid Signed on 04/12/24 @ 10:15 18[th] November 2024

_______ Richard Reid

Annual Report and Accounts for year ended 31 July 2024 Page 4

NATIONAL HEART & LUNG FOUNDATION

INDEPENDENT AUDITORS’ REPORT

Opinion

We have audited the financial statements of National Heart and Lung Foundation (the 'charity') for the year ended 31 July 2024 on pages seven to seventeen. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

This report is made solely to the charity's trustees, as a body, in accordance with Section 144 of the Charities Act 2011 and regulations made under Section 154 of that Act. Our audit work has been undertaken so that we might state to the charity's trustees those matters we are required to state to them in an auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charity and the charity's trustees as a body, for our audit work, for this report, or for the opinions we have formed.

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors responsibilities for the audit of the financial statements section of our report. We are independent of the charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The trustees are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our Report of the Independent Auditors thereon.

Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters where the Charities Act 2011 requires us to report to you if, in our opinion:

Annual Report and Accounts for year ended 31 July 2024 Page 5

NATIONAL HEART & LUNG FOUNDATION

INDEPENDENT AUDITORS’ REPORT

Responsibilities of trustees

As explained more fully in the Statement of Trustees Responsibilities set out on page four, the trustees are responsible for the preparation of the financial statements which give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the charity's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charity or to cease operations, or have no realistic alternative but to do so.

Our responsibilities for the audit of the financial statements

We have been appointed as auditor under section 144 of the Charities Act 2011 and report in accordance with the Act and relevant regulations made or having effect thereunder.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

.

Use of the audit report

This report is made solely to the charity’s trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. Our audit work has been undertaken, so that we might state to the charity’s trustees those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charity and the charity’s trustees as a body, for our audit work, for this report or for the opinions we have formed.

Knox Cropper LLP Signed on 04/12/24 @ 15:24

Knox Cropper LLP Chartered Accountants and Statutory Auditors Eligible to act as an auditor in terms of Section 1212 of the Companies Act 2006 65 Leadenhall Street London EC3A 2AD

Date: 18[th] November 2024

Annual Report and Accounts for year ended 31 July 2024 Page 6

NATIONAL HEART & LUNG FOUNDATION

STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31[ST] JULY 2024

------Unrestricted Funds------

Notes
INCOME AND
ENDOWMENTS FROM:
Donations and Legacies
2
Investment Income
3
TOTAL INCOME
EXPENDITURE ON:
Raising Funds
4
Charitable Activities
5
TOTAL RESOURCES
EXPENDED
Gain/(Loss) on Investments
9
NET MOVEMENT IN FUNDS
Fund Balances
at 1st August 2023
FUND BALANCES
AT 31ST JULY 2024
General
Fund
Endowment
Fund
Restricted
Viscount
Royston
Fellowship
Fund
2024
Total
2023
Total
£
£
£
£
£
387,706
-
-
387,706
157,733
424,154
-
87,636
511,790
502,029
811,860
-
87,636
899,496
659,762
59,973
-
12,204
72,177
84,644
104,378
-
-
104,378
724,433
164,351
-
12,204
176,555
809,077
581,437
839,552
299,198
1,720,187
(256,117)
1,228,946
839,552
374,630
2,443,128
(405,432)
4,013,073
14,717,615
2,412,995
21,143,683
21,549,155
5,242,019
15,557,167
2,787,625
23,586,811
21,143,683

The Charity has no recognised gains and losses other than those included in the figures above. All activities reflected above are continuing activities.

Annual Report and Accounts for year ended 31 July 2024 Page 7

NATIONAL HEART AND LUNG FOUNDATION

BALANCE SHEET AT 31[ST] JULY 2024

Notes
FIXED ASSETS
Investments
7-9
CURRENT ASSETS
Debtors
10
Cash at Bank
Creditors: Amounts falling due
within one year
11
Net Current Assets /
(Liabilities)
Total Assets less current
liabilities
Creditors: Amounts falling due
after one year
12
TOTAL NET ASSETS
RESTRICTED FUNDS
13
CAPITAL FUNDS
Expendable Endowment
13, 14
INCOME FUND
Unrestricted General Fund
13
TOTAL FUNDS
2024
£
£
23,734,713
23,734,713
388,400
33,809
422,209
(430,111)
(7,902)
23,726,811
(140,000)
£23,586,811
2,787,625
15,557,167
5,242,019
£23,586,811
2023
£
£
22,188,156
22,188,156
80,000
68,241
148,241
(910,108)
(761,867)
21,426,289
(282,606)
£21,143,683
2,412,995
14,717,615
4,013,073
£21,143,683
2023
£
£
22,188,156
22,188,156
80,000
68,241
148,241
(910,108)
(761,867)
21,426,289
(282,606)
£21,143,683
2,412,995
14,717,615
4,013,073
£21,143,683
21,426,289
(282,606)
£21,143,683
2,412,995
14,717,615
4,013,073
£21,143,683

Approved by the Board of Trustees on the 18[th] November 2024 and signed on its behalf by:

R H Reid Signed on 04/12/24 @ 10:15

______ Richard Reid Chairman

Annual Report and Accounts for year ended 31 July 2024 Page 8

NATIONAL HEART AND LUNG FOUNDATION

CASH FLOW STATEMENT FOR THE YEAR ENDED 31[ST] JULY 2024

CASH FLOWS FROM OPERATING ACTIVITIES
Notes
Cash used by operations
A
CASH FLOWS FROM INVESTING ACTIVITIES
Investment income received
Proceeds from the sale of investments
Purchase of investments
Change in cash and cash equivalents in the
reporting period
B
Cash and cash equivalents at the beginning of the
reporting period
Cash and cash equivalents at the end of the
reporting period
2024
£
(719,852)
511,790
800,440
(635,390)
676,840
(43,012)
94,128
51,116
2023
£
(1,174,229)
502,029
766,724
(499,104)
769,649
(404,580)
498,708
94,128

A. RECONCILIATION OF NET (EXPENDITURE)/INCOME TO NET CASH FLOW FROM OPERATING ACTIVITIES

Net (expenditure)/income for the reporting period (as per the Statement of
Financial Activities)
Investment income received
(Gains)/losses in investments (excluding cash balances)
(Increse) in debtors
(Decrease)/Increase in creditors
Net cash used by operations
2024
£
2,443,128
(511,790)
(1,720,187)
(308,400)
(622,603)
(719,852)
2023
£
(405,432)
(502,029)
256,117
(64,170)
(458,715)
(1,174,229)

B. ANALYSIS OF CHANGES IN NET FUNDS

Cash at bank and in hand
Cash held by investment manager
At 1 August
2023 £
68,241
25,887
94,128
Cash
flow £
(34,432)
(8,580)
(43,012)
At 31 July 2024
£
33,809
17,307
51,116

Annual Report and Accounts for year ended 31 July 2024 Page 9

NATIONAL HEART AND LUNG FOUNDATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31st JULY 2024

1. ACCOUNTING POLICIES

Annual Report and Accounts for year ended 31 July 2024 Page 10

NATIONAL HEART AND LUNG FOUNDATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31st JULY 2024

1. ACCOUNTING POLICIES (Continued)

The trustees of the charity have concluded that there are no material uncertainties related to events or conditions that may cast significant doubt on the ability of the charity to continue as a going concern. The trustees are of the opinion that the charity will have sufficient resources to meet its liabilities as they fall due.

2. DONATIONS AND LEGACIES

==> picture [485 x 73] intentionally omitted <==

----- Start of picture text -----
|||||| |---|---|---|---|---| |---------------------2024------------------------| |NHLF|VRFT|TOTAL|2023| |£|£|£|£| |Donations|55,806|-|55,806|60,208| |-| |Legacies|331,900|331,900|97,525| |387,706|-|387,706|157,733|

----- End of picture text -----

3. INVESTMENT INCOME

==> picture [483 x 213] intentionally omitted <==

----- Start of picture text -----
|||||| |---|---|---|---|---| |---------------------2024------------------------| |NHLF|VRFT|TOTAL|2023| |£|£|£|£| |Income from listed investments|421,709|87,181|508,890|499,104| |Interest on cash deposit|2,445|455|2,900|2,925| |424,154|87,636|511,790|502,029| |RAISING FUNDS| |-----------------------2024------------------| |NHLF|VRFT|TOTAL|2023| |£|£|£|£| |Investment Management Fees|57,788|12,204|69,992|82,708| |Advertising|1,605|-|1,605|1,605| |Computer Support|382|-|382|331| |Professional Fees|198|-|198|-| |59,973|12,204|72,177|84,644|

----- End of picture text -----

4. RAISING FUNDS

Annual Report and Accounts for year ended 31 July 2024 Page 11

NATIONAL HEART AND LUNG FOUNDATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31st JULY 2024

5. CHARITABLE ACTIVITIES

Direct Grants to NHLI Faculty of Medicine Imperial College London
- Endowment Fund
- General Fund
- VRFT
Support Costs (see note 6)
SUPPORT COSTS
Secretarial costs
Legal costs
Bank Charges
Governance costs
Audit fee
Legal and professional fees
Total Governance costs
2024
£
-
40,000
-
64,378
£104,378
12,070
35,516
216
47,802
6,480
10,096
16,576
64,378
2023
£
700,000
-
(50,000)
74,433
£724,433
12,312
40,589
217
53,118
6,420
14,895
21,315
74,433
  1. SUPPORT COSTS

Administration costs including the provision of a meeting room have been borne by Imperial College London. These costs are not material.

No remuneration directly or indirectly out of the funds of the Foundation was paid or is payable for the year to any of the Trustees.

No reimbursement of expenses has been made or is due to be made to any of the Trustees.

7. INVESTMENTS

Social Investments
Quoted Investments
Cash held for investment purposes
Total Investments
2024
£
4,909,975
18,807,430
17,307
23,734,712
2023
£
4,909,975
17,252,294
25,887
£22,188,156

Annual Report and Accounts for year ended 31 July 2024 Page 12

NATIONAL HEART AND LUNG FOUNDATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31st JULY 2024

8. INVESTMENTS – SOCIAL INVESTMENTS

2024 2023
£ £
Balance at 1stAugust 2023 and at 31stJuly 2024 4,909,975 £4,909,975

The Charity holds a 50% interest in the freehold of the property at 1B Manresa Road. This is occupied rent free by the National Heart and Lung Institute, Faculty of Medicine, Imperial College London. The building is disclosed at the amount at which it was transferred in 1995 from The National Heart and Lung Institute.

9. INVESTMENTS – QUOTED INVESTMENTS AND CASH HELD FOR INVESTMENT PURPOSES

PURPOSES
(a)
Quoted investments (at market value)
- NHLF
- Viscount Royston Fellowship Trust
Cash held for investment purposes
- NHLF
- Viscount Royston Fellowship Trust
2024
£
15,536,545
3,270,885
18,807,430
10,593
6,714
18,824,737
2023
£
14,372,294
2,880,000
17,252,294
869
25,018
£17,278,181

All the quoted investments are held in the form of units in unit trusts.

Annual Report and Accounts for year ended 31 July 2024 Page 13

NATIONAL HEART AND LUNG FOUNDATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31st JULY 2024

9. INVESTMENTS – QUOTED INVESTMENTS AND CASH HELD FOR INVESTMENT PURPOSES (Continued)

2024
£
(b)
Movements in quoted investments
Balance brought forward at 1stAugust
17,252,295
Additions
635,390
Sale proceeds
(800,442)
Realised and unrealised gain/(loss) - NHLF
1,615,201
- VRFT
104,986
Balance carried forward at 31stJuly
18,807,430
Investments at Cost – NHLF
12,037,796
Investment at Cost – VRFT
2,089,623
(c)
Investments held comprise units in one unit trusts:
4,260,089 (2023: 4,434,425) - Sarasin Alpha Charity Fund
(Accumulation)
15,536,545
896,969 (2023: 888,614) - Sarasin Alpha Charity Fund
(Accumulation) – VRFT
3,270,885
18,807,430
(d) The units held in unit trusts include the following asset allocations:-
Fixed Income
2,060,000
Equities
14,055,748
Property
658,766
Alternative Investments
1,422,848
Liquid Assets
627,374
18,824,737
10.DEBTORS
Other Debtors
388,400
£388,400
2023
£
17,776,031
499,104
(766,724)
(215,086)
(41,031)
17,252,294
£12,082,101
£1,975,942
14,372,294
2,880,000
£17,252,294
2,517,726
11,479,720
703,575
1,611,787
965,373
£17,278,181
80,000
£80,000

Annual Report and Accounts for year ended 31 July 2024 Page 14

NATIONAL HEART AND LUNG FOUNDATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31st JULY 2024

11.LIABILITIES: amounts falling due within one year
Grants payable to Imperial College London - VRFT
- General Fund
- Endowment Fund
Audit and Accountancy
Professional Fees
Other Creditors and deferred income
12.GRANTS PAYABLE
Commitments at 1stAugust 2023
Commitments made in the year
- General Fund
Commitments made in the year
- Endowment Fund
Commitments made in the year
- VRFT
Grants paid during the year
- General Fund
Grants paid during the year
- Endowment Fund
Grants paid during the year
- VRFT
Commitments at 31stJuly 2024
Commitments at 31stJuly 2024 are payable as follows:
Within one year
- General Fund
- Endowment Fund
- VRFT
After one year
- NHLF
- VRFT
2024
£
31,302
172,639
189,580
6,480
1,000
29,110
£430,111
2024
£
1,142,710
40,000
-
-
(210,788)
(335,431)
(102,970)
533,521
172,639
189,580
31,302
393,521
140,000
-
140,000
533,521
2023
£
116,667
218,426
525,011
6,180
1,000
42,824
£910,108
2023
£
1,600,454
-
700,000
(50,000)
(141,484)
(857,663)
(108,597)
£1,142,710
218,426
525,011
116,667
860,104
265,000
17,606
282,606
£1,142,710

13. FUNDS

UNDS
Unrestricted Funds
General funds
Endowment Funds
Restricted Funds
Viscount Royston
Fellowship Trust
Balance
Brought
Forward at 1
August 2023
Investment
Gain/(Loss)
Income
Resources
Expended
Balance
Carried
Forward at
31 July 2024
4,013,073
581,437
811,860
(164,351)
5,242,019
14,717,615
839,552
-
-
15,557,167
18,730,688
1,420,989
811,860
(164,351)
20,799,186
2,412,995
299,198
87,636
(12,204)
2,787,625
£21,143,683
£1,720,187
899,496
(£176,555)
£23,586,811

Annual Report and Accounts for year ended 31 July 2024 Page 15

NATIONAL HEART AND LUNG FOUNDATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31st JULY 2024

13. FUNDS (Continued)

UNDS(Continued)
Unrestricted Funds
General funds
Endowment Funds
Restricted Funds
Viscount Royston
Fellowship Trust
Balance
Brought
Forward at 1
August 2022
Investment
Gain/(Loss)
Income
Resources
Expended
Balance
Carried
Forward at
31 July 2023
3,653,774
(73,798)
578,475
(145,378)
4,013,073
15,558,903
(141,288)
-
(700,000)
14,717,615
19,216,677
(215,086)
578,475
(845,378)
18,730,688
2,336,438
(41,031)
81,287
36,301
2,412,995
£21,549,115
£(256,117)
£659,762
(£809,077)
£21,143,683

Viscount Royston Fellowship Trust Fund is dedicated in perpetuity for research into diseases of the heart muscle and into heart disease generally.

14. EXPENDABLE ENDOWMENT

The balance on Expendable Endowment represents donations and bequests received which could be expended at the Trustees’ discretion. Investment income arising on Endowment Fund assets can be applied to the generality of the Charity’s objects.

15. TAXATION

The National Heart and Lung Foundation is a registered charity and is exempt from taxation in respect of income and capital gains received within the categories covered by Part II of the Corporation Tax Act 2010 to the extent that such income or gains are applied for exclusively charitable purposes.

Annual Report and Accounts for year ended 31 July 2024 Page 16

NATIONAL HEART AND LUNG FOUNDATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31st JULY 2024

16. PRIOR YEAR COMPARATIVES

The breakdown between funds of income and expenditure for the year ending 31[st] July 2023 was as follows: -------Unrestricted Funds-------

The breakdown between f
unds of income and expenditure for the year ending 31stJuly 2
-------Unrestricted Funds-------
INCOME AND ENDOWMENTS
FROM:
Donations and Legacies
Investment Income
TOTAL INCOME
EXPENDITURE ON:
Raising Funds
Charitable Activities
TOTAL RESOURCES EXPENDED
Gain/(Loss) on Investments
NET MOVEMENT IN FUNDS
Fund Balances
at 1st August 2022
FUND BALANCES
AT 31ST JULY 2023
Unrestricted
General
Fund
Endowment
Fund
Restricted
Viscount
Royston
Fellowship
Fund
2023
Total
£
£
£
£
157,733
-
-
157,733
420,742
-
81,287
502,029
578,475
-
81,287
659,762
70,945
-
13,699
84,644
74,433
700,000
(50,000)
724,433
145,378
700,000
(36,301)
809,077
(73,798)
(141,288)
(41,031)
(256,117)
359,299
(841,288)
76,557
(405,432)
3,653,774
15,558,903
2,336,438
21,549,115
4,013,073
14,717,615
2,412,995
21,143,683

Annual Report and Accounts for year ended 31 July 2023 Page 17